Researchers examined whether reversion of beta cell autoantibodies has any effect on the risk of type 1 diabetes in children up to 10 years of age. Reversions were most restricted in children who had single autoantibodies and most rare in children who had developed multiple autoantibodies.
Vehik et al,. Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study. (2016). Diabetes Care 39 (9); 1535-1542, http://dx.doi.org/10.2337/dc16-0181.